These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38191019)

  • 1. Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
    How JA; Legarreta AF; Handley KF; Fellman B; Foster KI; Glassman D; Vuttaradhi VK; Brodsky AL; Lawson B; Frumovitz M; Westin SN; Ramondetta LM; Gershenson DM; Sood AK; Hillman RT
    Am J Obstet Gynecol; 2024 May; 230(5):544.e1-544.e13. PubMed ID: 38191019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experıance of tertıary center for adult granulosa cell tumor: whıch factors predıct survival?
    Şahin M; Arslanca T; Uçar YÖ; Güner GT; Selçuk İ; Yalçın HR
    J Ovarian Res; 2024 Jun; 17(1):127. PubMed ID: 38898511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study.
    Wang PH; Sun HD; Lin H; Wang KL; Liou WS; Hung YC; Chiang YC; Lu CH; Lai HC; Chang TC;
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):253-9. PubMed ID: 26166336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Foster KI; Flores Legarreta A; Kamat R; Handley KF; Glassman D; How JA; Lawson BC; Westin SN; Ramondetta LM; Frumovitz M; Gershenson DM; Sood AK; Hillman RT
    Am J Obstet Gynecol; 2023 Jun; 228(6):724.e1-724.e9. PubMed ID: 36907533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
    Shi T; Zhu J; Feng Y; Tu D; Zhang Y; Zhang P; Jia H; Huang X; Cai Y; Yin S; Jiang R; Tian W; Gao W; Liu J; Yang H; Cheng X; Zang R
    Lancet Oncol; 2021 Apr; 22(4):439-449. PubMed ID: 33705695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: A JSGO-JSOG joint study.
    Ebina Y; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Gynecol Oncol; 2021 Nov; 163(2):269-273. PubMed ID: 34454726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).
    Gurumurthy M; Bryant A; Shanbhag S
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006912. PubMed ID: 24753008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Shibata K; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2019 Jun; 29(5):910-915. PubMed ID: 30839284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
    Plett H; Ricciardi E; Vacaru V; Ramspott JP; Colombo N; Sehouli J; du Bois A; Garbi A; Richter R; Ataseven B; Aletti G; Braicu E; Heitz F; Portuesi R; Muallem MZ; Dagres T; Parma G; Roser E; Traut A; Multinu F; Harter P
    Int J Gynecol Cancer; 2023 May; 33(5):734-740. PubMed ID: 36759002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognosis and associated factors in multiple recurrent epithelial ovarian cancer with three times or more cytoreductive surgeries].
    Zou RY; Yuan L; Chen M; Yao LQ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Mar; 58(3):198-206. PubMed ID: 36935197
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
    Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
    Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of systemic chemotherapy in the management of granulosa cell tumors.
    Meisel JL; Hyman DM; Jotwani A; Zhou Q; Abu-Rustum NR; Iasonos A; Pike MC; Aghajanian C
    Gynecol Oncol; 2015 Mar; 136(3):505-11. PubMed ID: 25546114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
    Kumar S; Srinivasan A; Phillips A; Madhupriya R; Pascoe J; Nevin J; Elattar A; Balega J; Cummins C; Sundar S; Kehoe ST; Singh K
    J Obstet Gynaecol; 2020 Aug; 40(6):849-855. PubMed ID: 31933417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Chen J; Tang MQ; Liu Q; Cai SM
    J Surg Oncol; 2000 Sep; 75(1):24-30. PubMed ID: 11025458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
    Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE
    Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases.
    Fan XM; Zhang J; Niu SH; Li KX; Song CZ
    Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.